On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayJul 17, 2024 3:25 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Secures Contract for Juvenile Monitoring, Strengthening Leadership in EM Solutions

SuperCom Ltd. (NASDAQ: SPCB), an identification and digital monitoring solutions company, recently secured a new contract for monitoring juveniles transitioning through California’s justice system. “The case management services will be provided for the California client through SuperCom’s fully owned subsidiary, Leaders in Community Alternatives (“LCA”), which provides evidence-based, community-focused services and electronic monitoring programs as a private contractor to government agencies. The California contract reflects a trend worldwide for court and law enforcement advocates to seek privately contracted rehabilitative service and electronic monitoring (‘EM’) solutions providers that allow teen suspects to enjoy a measure of freedom and community integration while…

Continue Reading

WednesdayJul 17, 2024 1:05 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at the 73rd Emerging Growth Conference

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc. is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company is presenting at the 73rd Emerging Growth Conference, scheduled for July 17-18, 2024. Clene’s presentation is slated to begin at 4:45 p.m. EDT on July 18, with Rob Etherington, Clene’s President and CEO, and Morgan Brown, Clene’s CFO, giving the presentation. To view the full press release, visit https://ibn.fm/Ev3fc About Clene Inc. Clene (along with…

Continue Reading

WednesdayJul 17, 2024 10:24 am

QualityStocksNewsBreaks – HealthLynked Corp. (HLYK) Enters Strategic Partnership to Support Rollout of Telemedicine Services across the US

HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, is announcing a strategic partnership with HC Smart, Inc., a national telemedicine provider. The partnership, set to go live within the next four weeks, is expected to extend HealthLynked’s telemedicine services across the U.S. as well as significantly enhance the company’s offerings and accessibility. The announcement stated that the collaboration will integrate HC Smart’s advanced telemedicine capabilities into HealthLynked’s existing platform, providing nationwide coverage to all HealthLynked members. This initiative will offer HealthLynked Network members access to high-quality healthcare from the comfort of their homes by enabling reduced-cost telemedicine consultations as part…

Continue Reading

TuesdayJul 16, 2024 3:40 pm

QualityStocksNewsBreaks – Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Reports on Plans to Explore Eastern Extent at Duquesne West Gold Project

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH), an advanced-stage, gold-exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project, announced that it is exploring the eastern portion of the project. According to the announcement, that exploration includes a “conceptual open pit model toward the Nip Zone, focusing on untested potentially high-grade gold targets after completing 30% (2,500 meters) of the ongoing 8,000-meter drill program at the Duquesne West Gold Project.” The company reported robust thickness of high-grade gold intercepts at the Nip Zone, making the area a top priority for exploration. Noting that…

Continue Reading

TuesdayJul 16, 2024 3:15 pm

QualityStocksNewsBreaks – U.S. Government and Social Media Giants Tackle Synthetic Drug Distribution

The United States government’s recent memorandum with major social media companies, including Meta Platforms (NASDAQ: META), X and Snap (NYSE: SNAP), marks a significant step in the fight against the distribution of synthetic drugs online. Snap, known for its Snapchat application, is at the forefront of this initiative, showcasing its commitment to corporate responsibility. This collaboration aims to leverage the extensive reach and influence of these platforms to address a critical public health concern. Snap, alongside its peers Meta and X, plays a pivotal role in the digital ecosystem, with millions of users engaging on their platforms daily. The agreement to curb…

Continue Reading

TuesdayJul 16, 2024 1:27 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Makes Management Announcement, Plans for Strategic Growth

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is preparing for growth by executing a strategic growth plan. A key element of the plan includes expanding the company’s management team to enable efficient handling of a greater workload of projects and initiatives. With that in mind, the company has named Nelson Cabatuan as consulting chief strategic financial advisor; Cabatuan is currently serving as Lexaria CFO. In his new role, Cabatuan will leverage his skills in corporate finance and strategic industry relationships to focus on strategic opportunities. In addition, Lexaria is working on other research and development projects…

Continue Reading

TuesdayJul 16, 2024 1:05 pm

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Secures FDA Approval for New Form of Buntanetap

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced receipt of approval from the U.S. Food and Drug Administration (“FDA”) to transition to a new solid form of buntanetap in future clinical trials. “In June 2024, Annovis announced the filing of a composition of matter patent for the new crystal form of buntanetap and a provisional patent for the manufacturing process of this new form,” the announcement reads. “The company conducted comprehensive bridge studies in various solvents and in animals, comparing the old…

Continue Reading

MondayJul 15, 2024 1:27 pm

QualityStocksNewsBreaks – Volcon Inc. (NASDAQ: VLCN) Closes $12M Registered Direct

Volcon (NASDAQ: VLCN), an all-electric power sports company producing high-quality and sustainable electric vehicles for the outdoor community, recently closed a registered direct offering. The company secured aggregate gross proceeds of approximately $12 million in the transaction that closed on July 12, 2024. Aegis Capital Corp. acted as the exclusive placement agent for the offering. To view the full press release, visit https://ibn.fm/xoB2G About Volcon Inc. Based in the Austin, Texas area, Volcon was founded as the first all-electric power sports company producing high-quality and sustainable electric vehicles for the outdoor community. Volcon electric vehicles are the future of off-roading,…

Continue Reading

MondayJul 15, 2024 12:15 pm

QualityStocksNewsBreaks – Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Announces Completion of Business Combination with G Mining Ventures

Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has completed its business combination with G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF). The business combination was completed through a court-approved plan of arrangement under the Canada Business Corporations Act after GMIN shareholders and Reunion Gold securityholders approved the plan; the Ontario Superior Court of Justice also approved the transaction. According to the announcement, a newly incorporated successor issuer will hold and manage the combined business of GMIN and Reunion Gold and has acquired all of the issued and outstanding common shares in the capital of…

Continue Reading

MondayJul 15, 2024 11:15 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Obtains Notice of Allowance for Key Trademark Identified as ‘Integral’ to Platform Technology

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, has received a Notice of Allowance from the United States Patent and Trademark Office (“USPTO”). According to the announcement, the notice means that the USPTO anticipates granting the trademark registration covering the mark “AVERSA” after completing administrative processes. Nutriband's proprietary AVERSA(TM) abuse deterrent transdermal technology works to incorporate aversive agents into transdermal patches that make an experience unpleasant, thereby discouraging abuse of substances. This technology is especially significant for drugs such as fentanyl, which have a high potential for abuse. The company’s lead product under development is AVERSA Fentanyl. Nutriband is…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered